Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Cancer Res ; 61(10): 4272-7, 2001 May 15.
Article in English | MEDLINE | ID: mdl-11358855

ABSTRACT

157Gd is a potential agent for neutron capture cancer therapy (GdNCT). We directly observed the microdistribution of Gd in cultured human glioblastoma cells exposed to Gd-diethylenetriaminepentaacetic acid (Gd-DTPA). We demonstrated, with three independent techniques, that Gd-DTPA penetrates the plasma membrane, and we observed no deleterious effect on cell survival. A systematic microchemical analysis revealed a higher Gd accumulation in cell nuclei compared with cytoplasm. This is significant for prospective GdNCT because the proximity of Gd to DNA increases the cell-killing potential of the short-range, high-energy electrons emitted during the neutron capture reaction. We also exposed Gd-containing cells to thermal neutrons and demonstrated the GdNC reaction effectiveness in inducing cell death. These results in vitro stimulated in vivo Gd-DTPA uptake studies, currently underway, in human glioblastoma patients.


Subject(s)
Gadolinium/pharmacokinetics , Gadolinium/therapeutic use , Glioblastoma/metabolism , Glioblastoma/radiotherapy , Neutron Capture Therapy , Cell Death/radiation effects , Cell Membrane/metabolism , Cell Nucleus/metabolism , Cytoplasm/metabolism , Gadolinium DTPA/pharmacokinetics , Gadolinium DTPA/toxicity , Humans , Isotopes , Mass Spectrometry , Spectrometry, X-Ray Emission , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...